ARCHIVES

Mayo Clinic’s NCI Designation Extended To Arizona, Florida Sites

This article is from The Cancer Letter archive.

Vol. 28 No. 30 | July 26, 2002

Download PDF Visit The Full Archive

Related Articles

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007

Also Bristol-Myers Squibb Under Federal Investigation Over Plavix Deal.

July 28, 2006

At Least 25 CCOP Applicants Score High Enough To Virtually Assure Funding; Geography An Issue

May 13, 1983

Dial Access Offers Caner Consultation Services

February 21, 1975

HRSA: Discounts Owed on Some Orphan Drug Uses

October 24, 2014

Reponses To Ford’s Request For Scientific Rational Of Cigarette Regulation Based On Epidemiologic Studies

November 8, 1974